208 related articles for article (PubMed ID: 10659018)
1. Marked inhibition of glioblastoma target cell tumorigenicity in vitro by retrovirus-mediated transfer of a hairpin ribozyme against deletion-mutant epidermal growth factor receptor messenger RNA.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
J Neurosurg; 2000 Feb; 92(2):297-305. PubMed ID: 10659018
[TBL] [Abstract][Full Text] [Related]
2. Catalytic properties of hairpin ribozymes derived from Chicory yellow mottle virus and arabis mosaic virus satellite RNAs.
DeYoung M; Siwkowski AM; Lian Y; Hampel A
Biochemistry; 1995 Dec; 34(48):15785-91. PubMed ID: 7495810
[TBL] [Abstract][Full Text] [Related]
3. The sCYMV1 hairpin ribozyme: targeting rules and cleavage of heterologous RNA.
Lian Y; De Young MB; Siwkowski A; Hampel A; Rappaport J
Gene Ther; 1999 Jun; 6(6):1114-9. PubMed ID: 10455414
[TBL] [Abstract][Full Text] [Related]
4. A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis.
Nagane M; Coufal F; Lin H; Bögler O; Cavenee WK; Huang HJ
Cancer Res; 1996 Nov; 56(21):5079-86. PubMed ID: 8895767
[TBL] [Abstract][Full Text] [Related]
5. Uniform MDM2 overexpression in a panel of glioblastoma multiforme cell lines with divergent EGFR and p53 expression status.
Halatsch ME; Schmidt U; Unterberg A; Vougioukas VI
Anticancer Res; 2006; 26(6B):4191-4. PubMed ID: 17201132
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
[TBL] [Abstract][Full Text] [Related]
7. Regulation of HGF expression by ΔEGFR-mediated c-Met activation in glioblastoma cells.
Garnett J; Chumbalkar V; Vaillant B; Gururaj AE; Hill KS; Latha K; Yao J; Priebe W; Colman H; Elferink LA; Bogler O
Neoplasia; 2013 Jan; 15(1):73-84. PubMed ID: 23359207
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody recognizing human cancers with amplification/overexpression of the human epidermal growth factor receptor.
Jungbluth AA; Stockert E; Huang HJ; Collins VP; Coplan K; Iversen K; Kolb D; Johns TJ; Scott AM; Gullick WJ; Ritter G; Cohen L; Scanlan MJ; Cavenee WK; Old LJ
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):639-44. PubMed ID: 12515857
[TBL] [Abstract][Full Text] [Related]
9. Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.
Mishima K; Johns TG; Luwor RB; Scott AM; Stockert E; Jungbluth AA; Ji XD; Suvarna P; Voland JR; Old LJ; Huang HJ; Cavenee WK
Cancer Res; 2001 Jul; 61(14):5349-54. PubMed ID: 11454673
[TBL] [Abstract][Full Text] [Related]
10. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells.
Wang FS; Kobayashi H; Liang KW; Holland JF; Ohnuma T
Hum Gene Ther; 1999 May; 10(7):1185-95. PubMed ID: 10340550
[TBL] [Abstract][Full Text] [Related]
11. Inverse correlation of epidermal growth factor receptor messenger RNA induction and suppression of anchorage-independent growth by OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in glioblastoma multiforme cell lines.
Halatsch ME; Gehrke EE; Vougioukas VI; Bötefür IC; A-Borhani F; Efferth T; Gebhart E; Domhof S; Schmidt U; Buchfelder M
J Neurosurg; 2004 Mar; 100(3):523-33. PubMed ID: 15035290
[TBL] [Abstract][Full Text] [Related]
12. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.
Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK
Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of the hairpin ribozyme derived from the negative strand of arabis mosaic virus satellite RNA.
Hisamatsu S; Morikawa Y; Tomita R; Tanaka T; Sonoki S; Kikuchi Y
J Biochem; 1997 Aug; 122(2):352-7. PubMed ID: 9378713
[TBL] [Abstract][Full Text] [Related]
14. Selection of a high activity c-erbB-2 ribozyme using a fusion gene of c-erbB-2 and the enhanced green fluorescent protein.
Wiechen K; Zimmer C; Dietel M
Cancer Gene Ther; 1998; 5(1):45-51. PubMed ID: 9476966
[TBL] [Abstract][Full Text] [Related]
15. Sequence elements outside the catalytic core of natural hairpin ribozymes modulate the reactions differentially.
Bajaj P; Steger G; Hammann C
Biol Chem; 2011 Jul; 392(7):593-600. PubMed ID: 21657980
[TBL] [Abstract][Full Text] [Related]
16. Characterization of hairpin ribozyme reactions.
Bajaj P; Hammann C
Methods Mol Biol; 2014; 1103():97-111. PubMed ID: 24318889
[TBL] [Abstract][Full Text] [Related]
17. A novel functional genomics approach identifies mTERT as a suppressor of fibroblast transformation.
Li QX; Robbins JM; Welch PJ; Wong-Staal F; Barber JR
Nucleic Acids Res; 2000 Jul; 28(13):2605-12. PubMed ID: 10871412
[TBL] [Abstract][Full Text] [Related]
18. Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.
Sullenger BA; Cech TR
Science; 1993 Dec; 262(5139):1566-9. PubMed ID: 8248806
[TBL] [Abstract][Full Text] [Related]
19. Cis and trans reactions of hairpin ribozymes derived from the negative strand of arabis mosaic virus satellite RNA.
Tomita R; Morikawa Y; Hisamatsu S; Suzuki-Fujita K; Tanaka T; Sonoki S; Kikuchi Y
Nucleic Acids Symp Ser; 1995; (34):117-8. PubMed ID: 8841580
[TBL] [Abstract][Full Text] [Related]
20. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
Kobayashi H; Takemura Y; Miyachi H
Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
